LifeVantage (LFVN) Set to Announce Quarterly Earnings on Thursday

LifeVantage (NASDAQ:LFVN) is scheduled to be announcing its earnings results after the market closes on Thursday, May 2nd. Parties that wish to listen to the company’s conference call can do so using this link.

LifeVantage (NASDAQ:LFVN) last posted its earnings results on Tuesday, January 30th. The company reported $0.10 EPS for the quarter. LifeVantage had a net margin of 1.40% and a return on equity of 19.96%. The firm had revenue of $51.62 million during the quarter.

LifeVantage Trading Down 3.7 %

NASDAQ:LFVN opened at $6.17 on Thursday. The company has a 50-day moving average price of $6.59 and a 200-day moving average price of $6.42. LifeVantage has a 12 month low of $3.04 and a 12 month high of $8.69. The stock has a market cap of $79.40 million, a price-to-earnings ratio of 26.83 and a beta of 0.78.

About LifeVantage

LifeVantage Corporation engages in the identification, research, development, formulation, and sale of advanced nutrigenomic activators, dietary supplements, nootropics, pre- and pro-biotics, weight management, skin and hair care, bath and body, and targeted relief products. It offers Protandim, a dietary supplement; LifeVantage Omega+, a dietary supplement that combines DHA and EPA Omega-3 fatty acids, Omega-7 fatty acids, and vitamin D3; LifeVantage ProBio, a dietary supplement to support gut health; PhysIQ, a weight management system; LifeVantage IC Bright, a supplement to support eye and brain health, reduce eye fatigue and strain, supports cognitive functions, and support normal sleep patterns; Petandim for Dogs, a supplement to combat oxidative stress in dogs; and Axio, a nootropic energy drink mix.